Chai Discovery
Building AI models to accelerate pre-clinical drug discovery
$400MSeries C
Role not disclosedTC
Thrive Capital
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Thrive Capital builds and invests in internet, software and technology-enabled companies, combining an investment business with company incubation.
Thrive Incubations works with founders through idea exploration, product development and company launch. It is a route for entrepreneurs building a business from the beginning, alongside Thrive’s investments in existing companies.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $2.5B 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionIsomorphic Labs
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas
$2.1BSeries B
Role not disclosed